Cancer testis antigen, ropporin, is a potential target for multiple myeloma immunotherapy.
Chiriva-Internati M, Mirandola L, Yu Y, Jenkins MR, Gornati R, Bernardini G, Gioia M, Chiaramonte R, Cannon MJ, Kast WM, Cobos E.
Chiriva-Internati M, et al. Among authors: cannon mj.
J Immunother. 2011 Jul-Aug;34(6):490-9. doi: 10.1097/CJI.0b013e31821ca76f.
J Immunother. 2011.
PMID: 21654522